XIGDUO XR
NDC 0310-6250, dapagliflozin and metformin hydrochloride, tablet, film coated, extended release, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-6250
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205649
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-6250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPAGLIFLOZIN PROPANEDIOL5 mg/1
- METFORMIN HYDROCHLORIDE500 mg/1
Pharmacologic classes
Biguanide [EPC]; Biguanides [CS]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-6250-30 | 00310625030 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0310-6250-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ac8a0f7b-9f69-4495-abbc-3a47cd75a859NADAC price for package 00310625030
GET /v1/drugs/nadac/00310625030
Use it
Look up 0310-6250 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-6250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-6250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.